STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 216.06 USD -0.03% Market Closed
Market Cap: 21.3B USD
Have any thoughts about
STERIS plc?
Write Note

Net Margin
STERIS plc

8.5%
Current
6%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.5%
=
Net Income
434.8m
/
Revenue
5.1B

Net Margin Across Competitors

Country IE
Market Cap 21.3B USD
Net Margin
8%
Country US
Market Cap 205.2B USD
Net Margin
14%
Country US
Market Cap 193.1B USD
Net Margin
29%
Country US
Market Cap 148.6B USD
Net Margin
16%
Country US
Market Cap 132.9B USD
Net Margin
11%
Country IE
Market Cap 109.9B USD
Net Margin
13%
Country US
Market Cap 64.8B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 325.5B CNY
Net Margin
33%
Country US
Market Cap 42.2B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

STERIS plc
Glance View

Market Cap
21.3B USD
Industry
Health Care

STERRIS plc is a globally recognized leader in the field of infection prevention, surgical, and critical care solutions, committed to enhancing patient safety and healthcare efficiency. With a rich history spanning over 100 years, the company operates in more than 60 countries, offering a diverse range of products and services tailored to meet the needs of healthcare providers. STERIS’s innovative technologies, including sterilization and disinfection equipment, surgical tables, and integrated surgical suites, position it as a vital partner for hospitals and medical facilities striving to uphold high standards of patient care. This focus on innovation not only drives customer loyalty but also positions the company favorably in an industry that increasingly prioritizes safety and efficiency. For investors, STERIS presents a robust growth trajectory, bolstered by a strategic approach to acquisitions and an expansion into emerging markets. The company has consistently delivered strong financial results, reflecting resilience even amidst industry challenges. With an ongoing commitment to research and development, STERIS is well-positioned to leverage trends in healthcare modernization and increasing demand for infection control solutions. As global healthcare systems adapt to rising patient care standards and regulatory requirements, STERIS’s established reputation and forward-thinking strategies make it an attractive investment opportunity for those looking to capitalize on the evolving landscape of healthcare services.

STE Intrinsic Value
225.24 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.5%
=
Net Income
434.8m
/
Revenue
5.1B
What is the Net Margin of STERIS plc?

Based on STERIS plc's most recent financial statements, the company has Net Margin of 8.5%.